• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    OptimizeRx Corporation - Common Stock (NQ: OPRX )

    7.540 -0.620 (-7.60%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 129,801
    Open 8.200
    Bid (Size) 7.400 (6)
    Ask (Size) 12.12 (2)
    Prev. Close 8.160
    Today's Range 7.426 - 8.200
    52wk Range 6.920 - 16.64
    Shares Outstanding 17,618,607
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
    From OptimizeRx Corporation
    Via GlobeNewswire

    Performance

    YTD
    -46.30%
    -46.30%
    1 Month
    -10.34%
    -10.34%
    3 Month
    -26.15%
    -26.15%
    6 Month
    -37.06%
    -37.06%
    1 Year
    +1.48%
    +1.48%

    More News

    Read More
    A Closer Look at 5 Analyst Recommendations For OptimizeRx
    Via Benzinga
    Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
    Via Benzinga
    Expert Ratings For OptimizeRx
    Via Benzinga
    Where OptimizeRx Stands With Analysts
    Via Benzinga
    OPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    OptimizeRx Reports Second Quarter 2024 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
    From OptimizeRx Corporation
    Via GlobeNewswire
    New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
    From OptimizeRx Corporation
    Via GlobeNewswire
    Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
    Via Benzinga
    Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Nasdaq Surges 150 Points; Retail Sales Flat For April
    Via Benzinga
    OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    OptimizeRx Reports First Quarter 2024 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx to Participate in Upcoming Investor Conferences
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
    From OptimizeRx Corporation
    Via GlobeNewswire
    7 Top Undervalued Stocks Primed for a Multibagger Recovery
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.